Autologous bone marrow-derived mesenchymal stem cells therapy (Affiliated Hospital Of Nantong University)

N/A

Report date: 2025/06/10 20:00:09

Base Information

Drug NameAutologous bone marrow-derived mesenchymal stem cells therapy (Affiliated Hospital Of Nantong University)

Drug Alias NameABMSC

ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Source of cells > Bone Marrow-derivedCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy

Mechanisms of ActionStem cell replacements

TargetsUpdating

Therapy Area/IndicationsIschemic Stroke

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaPhase 2 Clinical

Originator CompaniesAffiliated Hospital Of Nantong University

China Registration ClassN/A

Develop Information

Active CompaniesAffiliated Hospital Of Nantong University

Inactive CompaniesN/A

Active IndicationsIschemic Stroke

Inactive IndicationsN/A

Other Information

ATC CodeN/A